Encompassing the chemotherapy hybrid was a ROS-sensitive polymeric nanoparticle, which improved the delivery, DNA-damaging activity, and subsequent cGAS-STING pathway activation in several cancer cell lines in vitro. This evidence concerns the gene STING1 and cancer.